Challenges AMNOG

Schönermark, M.P., Hollander, I., Temme, T. (2013)

Abstract

Please find the whole article (German only) at pharmind 2013, No. 12.

Strategy Report

Whitepaper: Revisiting Transparency

The Role of Confidential Rebates Under Germany's Medical Research Act

more

Blog

New Government in Germany

What the Coalition Agreement Means for Germany as a Pharma Hub

more

Blog

Kintiga unifies MAP Patient Access, AxTalis, and SKC with one name and one vision.

New brand, proven excellence

more

Blog

EU HTA at national level - First concrete transition proposed

A new draft ordinance shows concrete intentions for the national implementation of the EU HTA Regulation in Germany

more

to the top